BMP9 overexpression in HBV‐infected HCC cells could promote intra‐tumoural infiltration of cytotoxic lymphocytes via vascular normalisation by inhibiting the Rho‐ROCK‐MLC pathway, resulting in enhanced anti‐PD‐L1 immunotherapy. Here, MLC1 is linked to hepatocellular carcinoma.